Abingdon Health (LON:ABDX) Sets New 52-Week Low – Here’s What Happened

Abingdon Health Plc (LON:ABDX) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 5.68 ($0.07) and last traded at GBX 5.99 ($0.08), with a volume of 99893 shares traded. The stock had previously closed at GBX 6 ($0.08).

Abingdon Health Stock Performance

The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The stock’s 50 day moving average price is GBX 6.88 and its 200 day moving average price is GBX 7.60. The company has a market capitalization of £11.59 million, a P/E ratio of -14.56 and a beta of 0.13.

Abingdon Health (LON:ABDX) last released its earnings results on Monday, March 24th. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.